Humacyte, Inc. (HUMA)
CIK 1818382 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 277.8M shares as of Aug 10, 2026 (10-Q).⊙
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| October2025 Registered Direct Offering Warrants | 28.4M | not tagged | — | FV $0 |
| Public Warrants | 5.0M | not tagged | 5y | — |
| Loan Agreement Warrants | 4.3M | $0.8 | — | FV $2.2M |
| October2024 Registered Direct Offering Warrants | 2.8M | not tagged | — | FV $0 |
| Registered Direct Warrants180 Day October2024 | 2.8M | $5.28 | 0.5y | — |
| Registered Direct Warrants1640 Day October2024 | 2.8M | $5.28 | 4.5y | — |
| November2024 Registered Direct Offering Warrants | 1.4M | not tagged | — | FV $0 |
| Registered Direct Warrants180 Day November2024 | 1.4M | $5.34 | 0.5y | — |
| Registered Direct Warrants1640 Day November2024 | 1.4M | $5.34 | 4.5y | — |
| Other Warrants | 240,000 | not tagged | — | — |
| Warrant | 240,000 | $10.28 | — | — |
| Private Placement Warrants | 177,500 | not tagged | — | FV $0 |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 12, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 42.8M underlying shares, as reported Jun 30, 2026 (10-Q).
Reported exercise price: $11.5 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $15.7M as of Jun 30, 2026.
Rough fully diluted estimate: 320.6M = 277.8M O/S + 42.8M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed Aug 12, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 277.8M | Aug 10, 2026 |
| + October2025 Registered Direct Offering Warrants (if exercised) | 28.4M | Jun 30, 2026 |
| + Public Warrants (if exercised) | 5.0M | Jun 30, 2026 |
| + Loan Agreement Warrants (if exercised) | 4.3M | Jun 30, 2026 |
| + October2024 Registered Direct Offering Warrants (if exercised) | 2.8M | Jun 30, 2026 |
| + Registered Direct Warrants180 Day October2024 (if exercised) | 2.8M | Oct 4, 2024 |
| + Registered Direct Warrants1640 Day October2024 (if exercised) | 2.8M | Oct 4, 2024 |
| + November2024 Registered Direct Offering Warrants (if exercised) | 1.4M | Jun 30, 2026 |
| + Registered Direct Warrants180 Day November2024 (if exercised) | 1.4M | Nov 13, 2024 |
| + Registered Direct Warrants1640 Day November2024 (if exercised) | 1.4M | Nov 13, 2024 |
| + Other Warrants (if exercised) | 240,000 | Jun 30, 2026 |
| + Warrant (if exercised) | 240,000 | May 27, 2026 |
| + Private Placement Warrants (if exercised) | 177,500 | Jun 30, 2026 |
| Fully diluted estimate | 328.9M | +18.4% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $350.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 4 executed · 0 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full HUMA workspace